X4 Pharmaceuticals Stock Market Value
| XFOR Stock | USD 0.34 0.03 8.11% |
| Symbol | XFOR |
X4 Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of X4 Pharmaceuticals. If investors know XFOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about X4 Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Revenue Per Share 0.003 | Return On Assets (0.40) | Return On Equity 0.2177 |
The market value of X4 Pharmaceuticals is measured differently than its book value, which is the value of XFOR that is recorded on the company's balance sheet. Investors also form their own opinion of X4 Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is X4 Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because X4 Pharmaceuticals' market value can be influenced by many factors that don't directly affect X4 Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between X4 Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if X4 Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, X4 Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
X4 Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to X4 Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of X4 Pharmaceuticals.
| 12/06/2022 |
| 11/25/2024 |
If you would invest 0.00 in X4 Pharmaceuticals on December 6, 2022 and sell it all today you would earn a total of 0.00 from holding X4 Pharmaceuticals or generate 0.0% return on investment in X4 Pharmaceuticals over 720 days. X4 Pharmaceuticals is related to or competes with Terns Pharmaceuticals, Day One, PDS Biotechnology, Inozyme Pharma, Acumen Pharmaceuticals, Mereo BioPharma, and Elevation Oncology. X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and com... More
X4 Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure X4 Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess X4 Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 62.35 | |||
| Value At Risk | (10.61) | |||
| Potential Upside | 6.9 |
X4 Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for X4 Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as X4 Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use X4 Pharmaceuticals historical prices to predict the future X4 Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (2.21) | |||
| Treynor Ratio | (0.45) |
X4 Pharmaceuticals Backtested Returns
X4 Pharmaceuticals retains Efficiency (Sharpe Ratio) of -0.0545, which attests that the company had a -0.0545% return per unit of price deviation over the last 3 months. X4 Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out X4 Pharmaceuticals' information ratio of (0.08), and Market Risk Adjusted Performance of (0.44) to validate the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 1.48, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, X4 Pharmaceuticals will likely underperform. At this point, X4 Pharmaceuticals has a negative expected return of -0.54%. Please make sure to check out X4 Pharmaceuticals' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if X4 Pharmaceuticals performance from the past will be repeated sooner or later.
Auto-correlation | 0.26 |
Poor predictability
X4 Pharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between X4 Pharmaceuticals time series from 6th of December 2022 to 1st of December 2023 and 1st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of X4 Pharmaceuticals price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current X4 Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
X4 Pharmaceuticals lagged returns against current returns
Autocorrelation, which is X4 Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting X4 Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of X4 Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that X4 Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
X4 Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If X4 Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if X4 Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in X4 Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
X4 Pharmaceuticals Lagged Returns
When evaluating X4 Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of X4 Pharmaceuticals stock have on its future price. X4 Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, X4 Pharmaceuticals autocorrelation shows the relationship between X4 Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in X4 Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with X4 Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if X4 Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with XFOR Stock
| 0.82 | ME | 23Andme Holding | PairCorr |
| 0.76 | VALN | Valneva SE ADR | PairCorr |
| 0.66 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against XFOR Stock
| 0.64 | KZR | Kezar Life Sciences | PairCorr |
| 0.37 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.31 | MDGL | Madrigal Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to X4 Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace X4 Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back X4 Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling X4 Pharmaceuticals to buy it.
The correlation of X4 Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as X4 Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if X4 Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for X4 Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for XFOR Stock Analysis
When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.